ReviewJournal of fungi (Basel, Switzerland)2026
Fungal Sphingolipids: Biosynthesis Pathways, Structural Features and Biological Functions.
Review in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Sphingolipids are a class of amphipathic lipids characterized by a sphingoid base backbone, which can be classified into glycosphingolipids and sphingomyelins. They exhibit structural complexity and functional diversity, being widely distributed in eukaryotes and some bacterial species. Sphingolipids are important regulators of signal transduction and cellular homeostasis and are involved in numerous biological processes, including cell polarity establishment, energy metabolism, proliferation, and differentiation. However, research on fungal sphingolipids remains limited. This review provides an overview of sphingolipid species, structural features, and their biosynthesis and degradation in fungi. It also summarizes their essential functions in maintaining cell membrane structure, influencing morphological development, pathogenicity, and homeostasis, and participating in apoptosis. Additionally, the potential of antifungal agents targeting the sphingolipid pathway and their application prospects are discussed. Finally, current challenges and future directions in fungal sphingolipid research are highlighted to support the investigation of their mechanisms and the development of antifungal therapies targeting sphingolipid metabolic pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.